1 0

    FDA ANDA 207382 Approval Routing Summary (Zydus Pharmaceuticals)

    FDA ANDA 207382 Approval Routing Summary (Zydus Pharmaceuticals)

    $69.95 USD
    $69.95 USD
    Sale Sold out

    Contents: Approval Routing Summary

    Abbreviated New Drug Application (ANDA): 207382
    Company: ZYDUS
    Drug Name: TOPIRAMATE
    Dosage Form/Route: CAPSULE, EXTENDED RELEASE;ORAL
    Marketing Status: Prescription
    TE Code: AB1
    Action Date: 11/24/2017
    View full details